Genomic variant mapping insights are shedding new light on how small DNA changes influence human health. Advances in genetic technologies have enabled researchers to pinpoint specific genomic regions linked to diseases, but understanding which exact variants drive these risks has remained difficult—until now. A groundbreaking study published in Nature unveils a comprehensive genomic map that highlights thousands of critical DNA variants influencing traits like blood pressure, blood sugar levels, and disease susceptibility.
Advances in genetic technologies have revolutionized our understanding of the genome, enabling researchers to pinpoint regions linked to diseases. However, identifying the specific genetic changes that contribute to health issues has remained a challenge. A recent study has made significant strides in this area by developing a genomic map that highlights small changes in the DNA sequence. This breakthrough helps researchers better understand how specific genetic variants influence health traits such as blood pressure and blood sugar levels, as well as the likelihood of developing certain diseases. The findings were published in *Nature*.
In this study, scientists analyzed data from 220,000 genetic variants previously identified across five cell types. They created a method to evaluate the impact of these variants one at a time. This innovative approach may enhance disease risk predictions and aid in the development of new therapies.
Ryan Tewhey, a geneticist and associate professor at The Jackson Laboratory (JAX), stated, “For nearly two decades, genetic studies have identified where in the genome we need to look for disease risk, but not which specific DNA changes are responsible. Our study helps close this gap by working at the scale needed to confidently pinpoint the specific DNA changes that matter across thousands of regions all at once, rather than one by one.”
Many genetic studies have discovered variants that influence health conditions like heart disease. However, many of these variants occur in non-coding regions of the genome, which do not directly code for proteins. Instead, they often reside in regulatory sequences that control gene activity. While millions of such variants have been identified, their specific impacts remain less understood.
To address this gap, the researchers engineered a massively parallel reporter assay to test the effects of variants in various cell types, including blood, brain, and liver cells. They matched segments of DNA with a molecular tag to determine whether a variant increased, decreased, or had no effect on gene activity.
Key findings from the study include:
– Identification of over 13,000 single-base pair variants affecting gene expression.
– Approximately 11% of variants showed altered effects when in proximity to other variants.
– The risk of certain disorders may depend on combinations of variants rather than individual ones.
While further validation is needed, these findings provide valuable insights into the effects of genetic variants, paving the way for advancements in personalized medicine and the understanding of individual disorders. Tewhey added, “These findings do more than explain known disease associations. They provide training data to build predictive models of the effects of variants we haven’t yet studied or that remain undiscovered.”
Sources: The Jackson Laboratory, *Nature*.
Source: Labroots
